VivoSim Labs, Inc. (VIVS)
2.34
-0.25
(-9.65%)
USD |
NASDAQ |
Feb 06, 16:00
2.34
0.00 (0.00%)
After-Hours: 20:00
VivoSim Labs EPS Diluted (Quarterly) : -0.977 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ResMed, Inc. | 2.682 |
| Aprea Therapeutics, Inc. | -0.4664 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.545M |
| Revenue (Quarterly) | 0.028M |
| Total Expenses (Quarterly) | 2.573M |
| Enterprise Value | 1.108M |
| Gross Profit Margin (Quarterly) | -110.7% |
| Profit Margin (Quarterly) | -9.09K% |
| Earnings Yield | -33.90% |
| Normalized Earnings Yield | -33.90 |